Literature DB >> 22267459

Pentacam sensitivity and specificity in detecting occludable angles.

Gemma C M Rossi1, Luigia Scudeller, Alessio Delfino, Marta Raimondi, Sara Pezzotta, Martina Maccarone, Elena Antoniazzi, Gian Maria Pasinetti, Paolo Emilio Bianchi.   

Abstract

PURPOSE: To assess the sensitivity and specificity of Pentacam measurements in detection of occludable angles and to provide cutoff values.
METHODS: Observational, single-center, cross-sectional study on 64 Caucasian eyes: 28 (43.7%) primary narrow angles or primary angle-closure glaucoma, and 36 (56.2%) controls: all subjects were evaluated and classified by gonioscopy (Shaffer classification). The following measurements have been considered: superior and inferior anterior chamber angle (ACA), temporal and nasal ACA, anterior chamber depth (ACD) using 5 value representation (central, superior, inferior, nasal, temporal), and anterior chamber volume (ACV). Validity of Pentacam parameters to detect patients in Shaffer 0 or I class was assessed by receiver operating characteristic (ROC) curves analysis; cutoffs were chosen as to maximize sensitivity and specificity.
RESULTS: All the considered Pentacam measures were statistically different between the 2 groups (p<0.0001). All Shaffer grade groups differed in all parameters (p<0.001), except for grade 0 and I, which did not differ in any. Area under the curve ROC analysis revealed high discriminant power of all Pentacam measures: ACA = 0.94; ACD = 0.91; ACD central = 0.89; and ACV = 0.89. Chosen cutoff values (ACA = 22.4°; ACD = 1.12 mm; ACD central = 1.93 mm; ACV = 84 mm3) allowed correct classification of narrow angles.
CONCLUSIONS: The study pointed out a high power of Pentacam AVA, ACV, and ACD in detecting occludable angles. Pentacam is simple to use, reliable, and noncontact, provides parameters in a short period, and represents a possible screening tool.

Entities:  

Mesh:

Year:  2012        PMID: 22267459     DOI: 10.5301/ejo.5000108

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  7 in total

1.  Non-contact tests for identifying people at risk of primary angle closure glaucoma.

Authors:  Anish Jindal; Irene Ctori; Gianni Virgili; Ersilia Lucenteforte; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2020-05-28

2.  Changes in anterior chamber volume after implantation of posterior chamber phakic intraocular lens in high myopia.

Authors:  Yi Zhu; Haobin Zhu; Yan Jia; Jibo Zhou
Journal:  BMC Ophthalmol       Date:  2018-07-28       Impact factor: 2.209

3.  Identification of eyes at risk of acute primary angle-closure in elderly Japanese patients.

Authors:  Tetsuya Muto; Tomoharu Nishimura; Masaaki Sakamoto; Takenori Inomata; Shigeki Machida
Journal:  Clin Ophthalmol       Date:  2019-05-23

4.  Cluster analysis reveals patterns of age-related change in anterior chamber depth for gender and ethnicity: clinical implications.

Authors:  Jack Phu; Janelle Tong; Barbara Zangerl; Janet Ly Le; Michael Kalloniatis
Journal:  Ophthalmic Physiol Opt       Date:  2020-07-09       Impact factor: 3.117

5.  Safety and anterior chamber structure of evolution implantable Collamer lens implantation with short white-to-white corneal diameters.

Authors:  Xun Chen; Fang Chen; Xuanqi Wang; Yilin Xu; Mingrui Cheng; Tian Han; Xiaoying Wang; Xingtao Zhou
Journal:  Front Med (Lausanne)       Date:  2022-08-17

6.  Corvis Biomechanical Factor Facilitates the Detection of Primary Angle Closure Glaucoma.

Authors:  Chien-Chih Chou; Po-Jen Shih; Chun-Yuan Wang; Tzuu-Shuh Jou; Jun-Peng Chen; I-Jong Wang
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

7.  Fourier domain optical coherence tomography to assess the iridocorneal angle and correlation study in a large Caucasian population.

Authors:  José Ignacio Fernández-Vigo; Julián García-Feijóo; José María Martínez-de-la-Casa; Javier García-Bella; Pedro Arriola-Villalobos; Cristina Fernández-Pérez; José Ángel Fernández-Vigo
Journal:  BMC Ophthalmol       Date:  2016-04-18       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.